Digital Health: Innovative engineering technologies to improve the understanding and management of fatigue

Lead Research Organisation: University of Aberdeen
Department Name: Sch of Medicine, Medical Sci & Nutrition

Abstract

Fatigue is considered as a "final common pathway": a vague clinical symptom that can result from many different diseases and mechanisms. Our limited understanding of fatigue stems, in part, from its subjective and fluctuating nature and its complex interplay of parameters associated with "tiredness" such as sleep, exercise, and mood. This project will investigate sensory technologies to objectively, accurately and unobtrusively measure fatiguability, as an indicator of fatigue. These measurements will be correlated to sensed data (activity levels, sleep, heart rate, and others) and individuals' self-reports. Granular details will be obtained about patterns in the human fatigue experience. The results will reveal whether there could be distinct, clinically relevant fatigue phenotypes. We will also use longitudinal research (studying participants closely over a several week period). To date, longitudinal fatigue research been limited by statistical analysis methods (such as multilevel modelling) which are unable to detect subtle or complex relationships between fatigue and related life-style factors over time. We will use artificial intelligence algorithms to help analyse and classify these correlations within the sensed data, self-reports and qualitative data.

Publications

10 25 50
 
Description The award is active and data collection and analysis are in progress. The key findings so far relate to our patient facing work. Four successful focus groups were held on-line with individuals with long COVID and myeloma. We were able to get key insights into patterns of fatigue and lived experiences of fatigue. Long COVID fatigue and myeloma fatigue are qualitatively different: long COVID is characterised by high levels of cognitive fatigue and post exertional malaise, whereas myeloma fatigue varies predictably based on treatment cycles. We have further focus groups planned. The results of our patient facing work confirm our hypothesis that fatigue is not a single entity and that we may be able to objectively quantify and categorise fatigue based on underlying mechanisms.
We were also able to get participants with fatigue to give us their views and opinions about the technologies we plan to test and participants gave feedback about the design of an Ecological Momentary Assessment (EMA) Study.
The EMA study started in January and has recruited seven out of 40 participants so far.
Exploitation Route Data analysis is at an early stage.
Sectors Digital/Communication/Information Technologies (including Software),Healthcare